A. I. Fairushina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
A. I. Fairushina has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- R. A. Zamanova
Bashkir State Medical University, Ministry of Health of Russia
3 shared publications - Svetlana V. Piatnitskaia
Bashkir State Medical University
3 shared publications - Valentin Nikolaevich Pavlov
Башкирский государственный медицинский университет
3 shared publications - Shamil Makhmutovich Safin
Bashkir State Medical University
2 shared publications - Vladimir A. Smirnov
Sklifosovsky Research Institute for Emergency Medicine, Moscow Healthcare Department
2 shared publications - Vladimir Viktorovich Krylov
Pirogov Russian National Research Medical University
2 shared publications
Latest Publications
- Open Access
- 8 July 2026
- Published by Arterialnaya Gipertenziya in Translational Medicine
- Vol. 13 (2) , 177-187
Effect of hydrogel based on tissue extract of uterine leiomyoma enhances osteogenic activity of osteoblasts
Background. The extracellular matrix plays a key role in maintaining homeostasis and bone tissue regeneration by defining the conditions for cell differentiation and intercellular interactions. The native extracellular matrix is a complex three-dimensional network of structural proteins, glycoproteins, and proteoglycans that provide mechanical support to cells and transmit regulatory signals. 2D-culture systems do not reproduce the complex organization of the cellular microenvironment; therefore, the development of 3D-systems for bone tissue differentiation and remodeling in vitro remains an important challenge. Objective. To evaluate the biocompatibility of the hydrogel based on a tissue extract of uterine leiomyoma and its potential to regulate osteogenic differentiation and mineralization of osteoblasts in mono- and co-culture with endothelial cells. Materials and Methods. The tissue extract of uterine leiomyoma was obtained using a modified protocol originally developed for producing Matrigel®. Osteoblasts were cultured within the hydrogel in mono- and co-culture with endothelial cells under osteogenic conditions. Cell viability and morphology were assessed by live-cell microscopy. Mineralization of the extracellular matrix was evaluated using Alizarin Red S staining. Results. The hydrogel based on tissue extract of uterine leiomyoma demonstrated high biocompatibility toward osteoblasts, supporting their viability, promoting differentiation into osteocyte-like cells, and enhancing extracellular matrix mineralization. In co-culture with endothelial cells, these effects were further enhanced, indicating the important role of intercellular interactions. Conclusion. The hydrogel based on tissue extract of uterine leiomyoma represents a promising 3D culture model for the studying osteogenic differentiation of osteoblasts.
- 8 July 2026
- Published by Arterialnaya Gipertenziya in Translational Medicine
- Vol. 13 (2) , 177-187
Open AccessEffect of hydrogel based on tissue extract of uterine leiomyoma enhances osteogenic activity of osteoblasts
Background. The extracellular matrix plays a key role in maintaining homeostasis and bone tissue regeneration by defining the conditions for cell differentiation and intercellular interactions. The native extracellular matrix is a complex three-dimensional network of structural proteins, glycoproteins, and proteoglycans that provide mechanical support to cells and transmit regulatory signals. 2D-culture systems do not reproduce the complex organization of the cellular microenvironment; therefore, the development of 3D-systems for bone tissue differentiation and remodeling in vitro remains an important challenge. Objective. To evaluate the biocompatibility of the hydrogel based on a tissue extract of uterine leiomyoma and its potential to regulate osteogenic differentiation and mineralization of osteoblasts in mono- and co-culture with endothelial cells. Materials and Methods. The tissue extract of uterine leiomyoma was obtained using a modified protocol originally developed for producing Matrigel®. Osteoblasts were cultured within the hydrogel in mono- and co-culture with endothelial cells under osteogenic conditions. Cell viability and morphology were assessed by live-cell microscopy. Mineralization of the extracellular matrix was evaluated using Alizarin Red S staining. Results. The hydrogel based on tissue extract of uterine leiomyoma demonstrated high biocompatibility toward osteoblasts, supporting their viability, promoting differentiation into osteocyte-like cells, and enhancing extracellular matrix mineralization. In co-culture with endothelial cells, these effects were further enhanced, indicating the important role of intercellular interactions. Conclusion. The hydrogel based on tissue extract of uterine leiomyoma represents a promising 3D culture model for the studying osteogenic differentiation of osteoblasts.
- Open Access
- 19 June 2026
- Published by "MedINK" Publishing House in Russian journal of neurosurgery
- Vol. 28 (2) , 113-121
Materials based on spider silk for regenerative medicine
Материалы на основе шелка паутины для регенеративной медицины
- 19 June 2026
- Published by "MedINK" Publishing House in Russian journal of neurosurgery
- Vol. 28 (2) , 113-121
Open AccessMaterials based on spider silk for regenerative medicine
Материалы на основе шелка паутины для регенеративной медицины
- Open Access
- 1 March 2026
- Published by Scientific Research Institute - Ochapovsky Regional Clinical Hospital No 1 in Innovative Medicine of Kuban
- Vol. 11 (1) , 123-131
Application of Spider Silk-Based Materials in Regenerative Medicine: From In Vivo Studies to Clinical Use
This review examines the use of spider-silk-based materials in regenerative medicine. Spider silk possesses a unique combination of mechanical and biological properties, making it a promising biomaterial for tissue engineering. An analysis of in vivo studies in animal models and the first clinical trials is presented, demonstrating the ability of spider silk to direct cell growth, accelerate wound healing, and promote peripheral nerve regeneration. The prospects for large-scale production of spider silk and its medical applications are discussed.
- 1 March 2026
- Published by Scientific Research Institute - Ochapovsky Regional Clinical Hospital No 1 in Innovative Medicine of Kuban
- Vol. 11 (1) , 123-131
Open AccessApplication of Spider Silk-Based Materials in Regenerative Medicine: From In Vivo Studies to Clinical Use
This review examines the use of spider-silk-based materials in regenerative medicine. Spider silk possesses a unique combination of mechanical and biological properties, making it a promising biomaterial for tissue engineering. An analysis of in vivo studies in animal models and the first clinical trials is presented, demonstrating the ability of spider silk to direct cell growth, accelerate wound healing, and promote peripheral nerve regeneration. The prospects for large-scale production of spider silk and its medical applications are discussed.